109 related articles for article (PubMed ID: 10052407)
1. Desmoglein ELISAs: a novel diagnostic tool for pemphigus.
Nishikawa T
Arch Dermatol; 1999 Feb; 135(2):195-6. PubMed ID: 10052407
[No Abstract] [Full Text] [Related]
2. Limitations in enzyme-linked immunosorbent assays for antibodies against desmogleins 1 and 3 in patients with pemphigus.
Bystryn JC; Akman A; Jiao D
Arch Dermatol; 2002 Sep; 138(9):1252-3. PubMed ID: 12224997
[No Abstract] [Full Text] [Related]
3. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
[TBL] [Abstract][Full Text] [Related]
4. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
[TBL] [Abstract][Full Text] [Related]
5. Neonatal pemphigus vulgaris: IgG4 autoantibodies to desmoglein 3 induce skin blisters in newborns.
Parlowsky T; Welzel J; Amagai M; Zillikens D; Wygold T
J Am Acad Dermatol; 2003 Apr; 48(4):623-5. PubMed ID: 12664033
[TBL] [Abstract][Full Text] [Related]
6. Pemphigus erythematosus: detection of anti-desmoglein-1 antibodies by ELISA.
Gomi H; Kawada A; Amagai M; Matsuo I
Dermatology; 1999; 199(2):188-9. PubMed ID: 10559598
[No Abstract] [Full Text] [Related]
7. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
[TBL] [Abstract][Full Text] [Related]
8. DSG 3 and DSG 1-ELISA as a specific diagnostic tool in oral bullous diseases.
Sistig S; Lukac J; Vucicevic-Boras V; Malenica B
Eur J Med Res; 2002 Apr; 7(4):181-2. PubMed ID: 12017158
[No Abstract] [Full Text] [Related]
9. [Immunological tests: Anti desmoglein 1 and 3 antibody].
Amagai M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():571-4. PubMed ID: 16111335
[No Abstract] [Full Text] [Related]
10. An experience for ELISA for desmoglein 1, suggesting a possible diagnostic help to determine the initial therapy for pemphigus foliaceus.
Aoyama Y; Tsujimura Y; Funabashi M; Sato M; Kamiya H; Kitajima Y
Eur J Dermatol; 2000; 10(1):18-21. PubMed ID: 10694292
[TBL] [Abstract][Full Text] [Related]
11. A sensitive and restricted enzyme-linked immunosorbent assay for detecting a heterogeneous antibody population in serum from people suffering from a new variant of endemic pemphigus.
Abréu-Vélez AM; Yepes MM; Patiño PJ; Bollag WB; Montoya F
Arch Dermatol Res; 2004 Mar; 295(10):434-41. PubMed ID: 14730452
[TBL] [Abstract][Full Text] [Related]
12. Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus.
Hashimoto T; Komai A; Futei Y; Nishikawa T; Amagai M
Arch Dermatol; 2001 Jun; 137(6):735-8. PubMed ID: 11405762
[TBL] [Abstract][Full Text] [Related]
13. The clinical transition between pemphigus foliaceus and pemphigus vulgaris correlates well with the changes in autoantibody profile assessed by an enzyme-linked immunosorbent assay.
Komai A; Amagai M; Ishii K; Nishikawa T; Chorzelski T; Matsuo I; Hashimoto T
Br J Dermatol; 2001 Jun; 144(6):1177-82. PubMed ID: 11422038
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunosorbent assay as a helpful diagnostic tool for pemphigus erythematosus with equivocal histologic and immunofluorescent findings.
Desai A; Harris J; Motaparthi K
Dermatol Online J; 2018 Aug; 24(8):. PubMed ID: 30677852
[TBL] [Abstract][Full Text] [Related]
15. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3.
Cheng SW; Kobayashi M; Kinoshita-Kuroda K; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2002 Aug; 147(2):261-5. PubMed ID: 12174096
[TBL] [Abstract][Full Text] [Related]
16. Pemphigus--decoding the cellular language of cutaneous autoimmunity.
Edelson RL
N Engl J Med; 2000 Jul; 343(1):60-1. PubMed ID: 10882772
[No Abstract] [Full Text] [Related]
17. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies.
Inaoki M; Kodera M; Fujimoto A; Nousari HC; Anhalt GJ; Takehara K
Br J Dermatol; 2001 Mar; 144(3):610-3. PubMed ID: 11260026
[TBL] [Abstract][Full Text] [Related]
18. Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3.
Galvañ-Pérez Del Pulgar JI; Tercedor-Sánchez J; Jiménez-Gallo D; Linares-Barrios M
Actas Dermosifiliogr; 2016 Nov; 107(9):785-786. PubMed ID: 27340117
[No Abstract] [Full Text] [Related]
19. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
[TBL] [Abstract][Full Text] [Related]
20. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay.
Ishii K; Amagai M; Ohata Y; Shimizu H; Hashimoto T; Ohya K; Nishikawa T
J Am Acad Dermatol; 2000 May; 42(5 Pt 2):859-61. PubMed ID: 10767686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
